-
D. Boral Capital Reaffirms "Buy" Rating for ImmunityBio (NASDAQ:IBRX)
Источник: Buzz FX / 16 янв 2025 07:46:16 America/Chicago
D. Boral Capital Reaffirms "Buy" Rating for ImmunityBio (NASDAQ:IBRX) Written by MarketBeat January 16, 2025 Share Link copied to clipboard. ImmunityBio ( NASDAQ:IBRX - Get Free Report ) 's stock had its "buy" rating restated by equities re
Read more...